Legend Biotech Corporation (FRA:9LB)

Legend Biotech Statistics

Total Valuation

Legend Biotech has a market cap or net worth of EUR 5.79 billion. The enterprise value is 5.40 billion.

Market Cap	5.79B
Enterprise Value	5.40B

Important Dates

The next estimated earnings date is Friday, August 21, 2026.

Earnings Date	Aug 21, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.75%
Shares Change (QoQ)	+0.20%
Owned by Insiders (%)	0.17%
Owned by Institutions (%)	52.50%
Float	82.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	46.14
PS Ratio	5.86
PB Ratio	6.90
P/TBV Ratio	6.90
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-24.92
EV / Sales	5.53
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-53.81

Financial Position

The company has a current ratio of 2.13, with a Debt / Equity ratio of 0.40.

Current Ratio	2.13
Quick Ratio	2.01
Debt / Equity	0.40
Debt / EBITDA	n/a
Debt / FCF	-3.36
Interest Coverage	-6.41

Financial Efficiency

Return on equity (ROE) is -25.19% and return on invested capital (ROIC) is -27.20%.

Return on Equity (ROE)	-25.19%
Return on Assets (ROA)	-5.24%
Return on Invested Capital (ROIC)	-27.20%
Return on Capital Employed (ROCE)	-12.38%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	318,663
Profits Per Employee	-69,972
Employee Count	3,100
Asset Turnover	0.71
Inventory Turnover	26.79

Taxes

In the past 12 months, Legend Biotech has paid 11.80 million in taxes.

Income Tax	11.80M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +14.96% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+14.96%
50-Day Moving Average	20.36
200-Day Moving Average	22.03
Relative Strength Index (RSI)	70.34
Average Volume (20 Days)	3

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	6.43

Income Statement

In the last 12 months, Legend Biotech had revenue of EUR 987.85 million and -216.91 million in losses. Loss per share was -1.20.

Revenue	987.85M
Gross Profit	197.57M
Operating Income	-116.74M
Pretax Income	-205.12M
Net Income	-216.91M
EBITDA	-108.50M
EBIT	-116.74M
Loss Per Share	-1.20

Balance Sheet

The company has 723.85 million in cash and 337.64 million in debt, with a net cash position of 386.21 million.

Cash & Cash Equivalents	723.85M
Total Debt	337.64M
Net Cash	386.21M
Net Cash Per Share	n/a
Equity (Book Value)	839.29M
Book Value Per Share	4.52
Working Capital	497.48M

Cash Flow

In the last 12 months, operating cash flow was -70.86 million and capital expenditures -29.57 million, giving a free cash flow of -100.43 million.

Operating Cash Flow	-70.86M
Capital Expenditures	-29.57M
Depreciation & Amortization	8.19M
Net Borrowing	-3.53M
Free Cash Flow	-100.43M
FCF Per Share	n/a

Margins

Gross margin is 20.00%, with operating and profit margins of -11.82% and -21.96%.

Gross Margin	20.00%
Operating Margin	-11.82%
Pretax Margin	-20.76%
Profit Margin	-21.96%
EBITDA Margin	-10.98%
EBIT Margin	-11.82%
FCF Margin	n/a

Dividends & Yields

Legend Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.75%
Shareholder Yield	-0.75%
Earnings Yield	-3.75%
FCF Yield	-1.74%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Legend Biotech has an Altman Z-Score of 4.27 and a Piotroski F-Score of 3.

Altman Z-Score	4.27
Piotroski F-Score	3